We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
191 hedge funds and large institutions have $708M invested in Anika Therapeutics in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 75 increasing their positions, 68 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 20
10% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 68
2% less funds holding
Funds holding: 194 → 191 (-3)
4.94% less ownership
Funds ownership: 100.66% → 95.72% (-4.9%)
7% less capital invested
Capital invested by funds: $761M → $708M (-$53.2M)
93% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $17M
Holders
191
Holders Change
-3
Holders Change %
-1.55%
% of All Funds
3.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
75
Reduced
68
Closed
20
Calls
$1.24M
Puts
$17M
Net Calls
-$15.7M
Net Calls Change
+$11.7M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$8.06M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.26M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.49M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.39M |
| 5 |
Renaissance Technologies
New York
|
+$5.94M |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$10.8M |
| 2 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$8.82M |
| 3 |
Millennium Management
New York
|
-$5.57M |
| 4 |
D.E. Shaw & Co
New York
|
-$5.11M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.93M |
